![Choon-Gu Choi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Choon-Gu Choi
Direktör/Styrelseledamot på
DB FINANCE NO.11 SPECIAL PURPOSE ACQUISITION CO., LTD.
Profil
Mr. Choon-Gu Choi is an Independent Director at ViGenCell, Inc., an Independent Director at DB Finance No.
11 Special Purpose Acquisition Co., Ltd., an Independent Director at GI Innovation, Inc. and an Independent Director at Mirae Asset Vision Special Purpose Acquisition 6 Co. He is on the Board of Directors at ViGenCell, Inc., DB Finance No.
11 Special Purpose Acquisition Co., Ltd., GI Innovation, Inc. and Mirae Asset Vision Special Purpose Acquisition 6 Co. Mr. Choi was previously employed as a Head-Compliance Audit by Mirae Asset Securities Co., Ltd. He received his graduate degree from Hanyang University.
Aktiva positioner av Choon-Gu Choi
| Företag | Position | Start |
|---|---|---|
| DB FINANCE NO.11 SPECIAL PURPOSE ACQUISITION CO., LTD. | Direktör/Styrelseledamot | 2023-04-04 |
| GI INNOVATION, INC. | Direktör/Styrelseledamot | - |
| VIGENCELL INC. | Direktör/Styrelseledamot | 2025-03-27 |
Tidigare kända positioner av Choon-Gu Choi
| Företag | Position | Slut |
|---|---|---|
| MIRAE ASSET SECURITIES CO., LTD. | Compliance Officer | - |
Choon-Gu Chois utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
20
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Hanyang University
 Hanyang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirae Asset Securities Co., Ltd.
 Mirae Asset Securities Co., Ltd. Investment Banks/BrokersFinance Provides bond dealing, wealth management, investment banking and financial consulting services | Finance |
ViGenCell, Inc.
 ViGenCell, Inc. BiotechnologyHealth Technology Develops immune cell therapy | Health Technology |
GI Innovation, Inc.
 GI Innovation, Inc. BiotechnologyHealth Technology Engages in research and development of immunotherapy drugs based on fusion proteins | Health Technology |
DB Finance No. 11 Special Purpose Acquisition Co., Ltd.
 DB Finance No. 11 Special Purpose Acquisition Co., Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
